FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

FDA Blocks Lawmakers from Attending Cancer Drug Meeting

A new Bloomberg report finds that two Republican lawmakers were barred from attending a 12/3 FDA meeting concerning the potential expanded approval of...

latest-news-card-1
Human Drugs

FDA Grants Full Approval to Lillys Jaypirca

FDA awards Eli Lilly traditional approval for Jaypirca (pirtobrutinib) and its use in adults with relapsed or refractory chronic lymphocytic leukemia ...

latest-news-card-1
Human Drugs

Integrate Key Teams for CNPV Success: Expert

Veristat principal regulatory specialist John Kirk outlines FDAs Commissioners National Priority Voucher program and how sponsors can succeed with the...

latest-news-card-1
Human Drugs

FDA Taps Tracy Beth Heg as Acting CDER Director

FDA names physicianepidemiologist Tracy Beth Heg as CDER acting director, replacing director Richard Pazdur, who submitted his retirement paperwork ea...

latest-news-card-1
FDA General

Former FDA Heads Warn on Prasads New Vaccine Policies

A dozen former FDA commissioners warn that sweeping internal directives proposed by CBER director Vinay Prasad would undermine evidence-based vaccine ...

latest-news-card-1
Human Drugs

Rhyz Analytical Labs CGMP Violations

FDA warns Provo, UT-based Rhyz Analytical Labs about CGMP violations in its work as a contract testing laboratory.

Human Drugs

Multiple Turbare Manufacturing Violations

FDA warns Conway, AR-based Turbare Manufacturing about CGMP and other violations in its work as an outsourcing facility producing sterile drug product...

latest-news-card-1
Human Drugs

QTc Information Labeling Guidance

FDA publishes a guidance to assist applicants in incorporating heart rate-corrected (QTc) interval of prolongation-related information in the labeling...

latest-news-card-1
Human Drugs

Judge Strikes Down FDA Decision Blocking Priority Voucher

A Washington, DC, federal judge rules that FDA acted unlawfully when it denied a priority review voucher to Sun Pharma and its drug Sezaby, the first ...

latest-news-card-1
Human Drugs

New CDER Director Pazdur Files Retirement Papers

Weeks into his new appointment, CDER director Richard Pazdur files paperwork to retire by the end of the month.